Anna’s practice spans a wide array of technologies in the chemical field. She has particular expertise and interest in areas such as small molecule pharmaceutical chemistry, targeted protein degradation (for example, PROTACs and molecular glues), polymorphs, pharmaceutical formulations, combination therapies, radiopharmaceuticals, composite materials and medical devices.
Anna provides strategic advice to clients throughout the drug development and clinical trial process, as well as for marketed drug products. She is experienced in managing multi-national patent portfolios and in securing supplementary protection certificates (SPCs) across Europe for approved drug products.
Anna is skilled in drafting and prosecuting patent applications in both Europe and the US, and works closely with a range of clients, from universities and SMEs to large, multinational companies to provide tailored, commercially-focused advice.
Anna holds a DPhil in Organic Chemistry from the University of Oxford, where her research focused on development of novel catalytic methodologies for synthesis of saturated nitrogen heterocycles. Prior to this, she graduated with an MSci in Chemistry with Industrial Experience from the University of Bristol, and gained valuable commercial insight during a year-long placement at a global pharmaceutical company.